Multiple imputation strategies for a bounded outcome variable in a competing risks analysis.

bounded data competing risks missing data multiple imputation predictive mean matching

Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
15 04 2021
Historique:
received: 06 12 2019
revised: 04 09 2020
accepted: 29 12 2020
pubmed: 21 1 2021
medline: 30 6 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

In patient follow-up studies, events of interest may take place between periodic clinical assessments and so the exact time of onset is not observed. Such events are known as "bounded" or "interval-censored." Methods for handling such events can be categorized as either (i) applying multiple imputation (MI) strategies or (ii) taking a full likelihood-based (LB) approach. We focused on MI strategies, rather than LB methods, because of their flexibility. We evaluated MI strategies for bounded event times in a competing risks analysis, examining the extent to which interval boundaries, features of the data distribution and substantive analysis model are accounted for in the imputation model. Candidate imputation models were predictive mean matching (PMM); log-normal regression with postimputation back-transformation; normal regression with and without restrictions on the imputed values and Delord and Genin's method based on sampling from the cumulative incidence function. We used a simulation study to compare MI methods and one LB method when data were missing at random and missing not at random, also varying the proportion of missing data, and then applied the methods to a hematopoietic stem cell transplantation dataset. We found that cumulative incidence and median event time estimation were sensitive to model misspecification. In a competing risks analysis, we found that it is more important to account for features of the data distribution than to restrict imputed values based on interval boundaries or to ensure compatibility with the substantive analysis by sampling from the cumulative incidence function. We recommend MI by type 1 PMM.

Identifiants

pubmed: 33469974
doi: 10.1002/sim.8879
pmc: PMC8611803
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1917-1929

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Statistics in Medicine published by John Wiley & Sons, Ltd.

Références

Comput Stat Data Anal. 2010 Apr 1;54(4):1109-1116
pubmed: 25419022
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Stat Methods Med Res. 2015 Aug;24(4):462-87
pubmed: 24525487
Psychol Methods. 2001 Dec;6(4):330-51
pubmed: 11778676
Stat Med. 2017 Feb 20;36(4):606-617
pubmed: 27862164
Biol Blood Marrow Transplant. 2017 Oct;23(10):1729-1735
pubmed: 28687394
Haematologica. 2017 May;102(5):958-966
pubmed: 28302712
Comput Methods Programs Biomed. 2019 May;173:167-176
pubmed: 31046992
Stat Methods Med Res. 2005 Dec;14(6):539-52
pubmed: 16355542
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19952-7
pubmed: 19901324
Eur J Haematol. 2011 Aug;87(2):172-81
pubmed: 21599753
Stat Med. 2014 Jan 15;33(1):88-104
pubmed: 23922236
Biometrics. 2014 Mar;70(1):1-9
pubmed: 24400873
Biol Blood Marrow Transplant. 2016 May;22(5):879-83
pubmed: 26743342
Am J Obstet Gynecol. 2014 May;210(5):457.e1-9
pubmed: 24674712
Biometrics. 1989 Mar;45(1):1-11
pubmed: 2497809
Biometrics. 2001 Mar;57(1):74-80
pubmed: 11252621
J Affect Disord. 2014 Oct;168:407-14
pubmed: 25108277
Biostatistics. 2016 Oct;17(4):751-63
pubmed: 27179002
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Stat Med. 2021 Apr 15;40(8):1917-1929
pubmed: 33469974
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
Stat Med. 2007 Feb 20;26(4):769-81
pubmed: 16755528
Biom J. 2018 Jul;60(4):734-747
pubmed: 29577376
Stat Med. 1999 Mar 30;18(6):681-94
pubmed: 10204197
Biometrics. 2000 Mar;56(1):199-203
pubmed: 10783796
Stat Med. 2006 Dec 30;25(24):4279-92
pubmed: 16947139
Stat Med. 2017 Oct 15;36(23):3683-3707
pubmed: 28608412
BMC Med Res Methodol. 2014 Apr 26;14:57
pubmed: 24766825
Am J Ophthalmol. 2016 Oct;170:50-57
pubmed: 27491697
BMC Med Res Methodol. 2014 Jun 05;14:75
pubmed: 24903709

Auteurs

Elinor Curnow (E)

Department of Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, UK.
Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Rachael A Hughes (RA)

Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Kate Birnie (K)

Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Michael J Crowther (MJ)

Biostatistics Research Group, Department of Health Sciences, University of Leicester, George Davies Centre, Leicester, UK.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Margaret T May (MT)

Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Kate Tilling (K)

Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH